BIOMAT Database Logo BIOMAT Database Logo

Interaction of human serum albumin with anticancer agents in vitro. 1980

I Takahashi, and T Ohnuma, and S Kavy, and S Bhardwaj, and J F Holland

The influence of human serum albumin (HA) on the biological effects of 13 chemotherapeutic agents was studied in vitro in the human leukaemia cell line MOLT-3. On the basis of changes in biological activity influenced by HA, these drugs may be divided into three types. Type I agents include cis-diamminedichloroplatinum (II), 4'-(9-acridinylamino)methanesulphon-m-anisidide, neocarzinostatin, nitrogen mustard, adriamycin, daunorubicin and mitomycin C--drugs whose biological activities are reduced in the presence of HA. The biological activities of Type II drugs (cytosine arabinoside, fluorouracil and actinomycin D) are not influenced by HA. The biological activities of Type III drugs (bleomycin, vincristine and vinblastine) are increased in the presence of HA. These results indicate that serum HA interferes in vitro with certain anticancer agents in terms of biological activity and, probably, clinical effectiveness. HA-drug interaction may be a major factor governing the pharmacology of Type I anticancer agents in man.

UI MeSH Term Description Entries
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D012709 Serum Albumin A major protein in the BLOOD. It is important in maintaining the colloidal osmotic pressure and transporting large organic molecules. Plasma Albumin,Albumin, Serum
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

I Takahashi, and T Ohnuma, and S Kavy, and S Bhardwaj, and J F Holland
Interaction of aurothiomalate with human serum albumin in vitro.
January 1976, Biochemical Society transactions,
I Takahashi, and T Ohnuma, and S Kavy, and S Bhardwaj, and J F Holland
Synthesis and in vitro evaluation of novel triazine analogues as anticancer agents and their interaction studies with bovine serum albumin.
July 2016, European journal of medicinal chemistry,
I Takahashi, and T Ohnuma, and S Kavy, and S Bhardwaj, and J F Holland
Theoretical aspects of interaction of the anticancer drug cytarabine with human serum albumin.
March 2023, Structural chemistry,
I Takahashi, and T Ohnuma, and S Kavy, and S Bhardwaj, and J F Holland
Interaction of bishydroxycoumarin with human serum albumin.
February 1971, Journal of pharmaceutical sciences,
I Takahashi, and T Ohnuma, and S Kavy, and S Bhardwaj, and J F Holland
Interaction of isofraxidin with human serum albumin.
January 2004, Bioorganic & medicinal chemistry,
I Takahashi, and T Ohnuma, and S Kavy, and S Bhardwaj, and J F Holland
Interaction of cimetidine with human serum albumin.
October 1990, Biochemical pharmacology,
I Takahashi, and T Ohnuma, and S Kavy, and S Bhardwaj, and J F Holland
Interaction of Citrinin with Human Serum Albumin.
December 2015, Toxins,
I Takahashi, and T Ohnuma, and S Kavy, and S Bhardwaj, and J F Holland
Interaction of sanguinarine with human serum albumin.
July 1993, Die Pharmazie,
I Takahashi, and T Ohnuma, and S Kavy, and S Bhardwaj, and J F Holland
Interaction of taxol with human serum albumin.
March 2000, Biochimica et biophysica acta,
I Takahashi, and T Ohnuma, and S Kavy, and S Bhardwaj, and J F Holland
[Interaction of human serum albumin with luminol].
January 1975, Biofizika,
Copied contents to your clipboard!